PROTO, Vittoria
PROTO, Vittoria
ENPP1 expression and metformin efficacy in type 2 diabetes
2010 Ludovico, O; Farina, Mg; Prudente, S; Palena, Ap; Proto, V; Marotta, V; Frittitta, L; Trischitta, V
Gene Expression and Metformin Efficacy in Type 2 Diabetes (T2D)
2013 Prudente, S; Masotti, A; Copetti, M; Caporarello, N; Proto, V; Da Sacco, L; Morini, E; Mercuri, L; Bailetti, D; Palena, A; Baratta, R; De Cosmo, S; Pellegrini, F; Ludovico, O; Frittitta, L; Trischitta, V.
Genetic Variability at the SH2B1Obesity Locus Is Associated with Risk of Myocardial Infarction in Patients with Type 2 Diabetes (T2D)
2011 Prudente, S; Morini, E; Larmon, J; Andreozzi, F; Gervino, Ev; Mannino, G; Bacci, S; Hauser, Th; Bellacchio, E; Pellegrini, F; Proto, V; Menzaghi, C; Sesti, G; Doria, A; Trischitta, V
IRS-1 G972R and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of "low frequency-low risk" variants
2009 Morini, E; Prudente, S; Succurro, E; Chandalia, M; Zhang, Yy; Mammarella, S; Pellegrini, F; Powers, C; Proto, V; Dallapiccola, B; Cama, A; Sesti, G; Abate, N; Doria, A; Trischitta, V
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ENPP1 expression and metformin efficacy in type 2 diabetes | 2010 | Ludovico, O; Farina, Mg; Prudente, S; Palena, Ap; Proto, V; Marotta, V; Frittitta, L; Trischitta, V | |
| Gene Expression and Metformin Efficacy in Type 2 Diabetes (T2D) | 2013 | Prudente, S; Masotti, A; Copetti, M; Caporarello, N; Proto, V; Da Sacco, L; Morini, E; Mercuri, L; Bailetti, D; Palena, A; Baratta, R; De Cosmo, S; Pellegrini, F; Ludovico, O; Frittitta, L; Trischitta, V. | |
| Genetic Variability at the SH2B1Obesity Locus Is Associated with Risk of Myocardial Infarction in Patients with Type 2 Diabetes (T2D) | 2011 | Prudente, S; Morini, E; Larmon, J; Andreozzi, F; Gervino, Ev; Mannino, G; Bacci, S; Hauser, Th; Bellacchio, E; Pellegrini, F; Proto, V; Menzaghi, C; Sesti, G; Doria, A; Trischitta, V | |
| IRS-1 G972R and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of "low frequency-low risk" variants | 2009 | Morini, E; Prudente, S; Succurro, E; Chandalia, M; Zhang, Yy; Mammarella, S; Pellegrini, F; Powers, C; Proto, V; Dallapiccola, B; Cama, A; Sesti, G; Abate, N; Doria, A; Trischitta, V |